Laddar...
A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment
BACKGROUND: To date, no therapeutic option has been established for sudden deafness refractory to systemic corticosteroids. This study aimed to examine the efficacy and safety of topical insulin-like growth factor-1 (IGF-1) therapy in comparison to intratympanic corticosteroid therapy. METHODS: We r...
Sparad:
I publikationen: | BMC Med |
---|---|
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
BioMed Central
2014
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236431/ https://ncbi.nlm.nih.gov/pubmed/25406953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-014-0219-x |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|